Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Influence of Ang-(1-7) intervention on ACE2-Ang (1-7)-Mas pathway activity, hepatic glucose metabolism and insulin resistance in type-2 diabetic rats

Yufang Liu¹, Fang Wang² , Xiue Xu³, Hui Cong⁴, Guiyan Chen⁵

¹Department of Radiology; ²Department of Nuclear Medicine, The People's Hospital of Binzhou, Binzhou 256610; ³Department of 3M, Yangxin TCM Hospital of Shandong Province, Yangxin 251800; ⁴Department of Pharmacy, Wudi People's Hospital, Wudi 251900; ⁵Department of Endocrine, The People's Hospital of Binzhou, Binzhou 256610, China.

For correspondence:- Fang Wang Email: vxg00w@163.com

Accepted: 29 April 2019 Published: 31 May 2019

Citation: Liu Y, Wang F, Xu X, Cong H, Chen G. Influence of Ang-(1-7) intervention on ACE2-Ang (1-7)-Mas pathway activity, hepatic glucose metabolism and insulin resistance in type-2 diabetic rats. Trop J Pharm Res 2019; 18(5):995-999 doi: 10.4314/tjpr.v18i5.12

© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To study the effects of angiotensin-(1-7) (angiot (1-7) intervention on angiotensin converting enzyme (ACE)-angiot-(1-7)-Mas pathway, hepatic glucose metabolism, and insulin resistance in rats with type 2 diabetes.

Methods: Thirty-six Sprague Dawley rats were randomly divided into normal control, diabetic control and study groups (12 rats per group). Rats in the normal group were fed normal feed, while rats in the observation and diabetic control groups were type-2 diabetes model, and were given subcutaneous injection of angiot-(1-7) for 8 weeks. Serum insulin resistance index (IRI) and fasting insulin (FINS) were assayed. Other parameters measured were the levels of ACE2 and Mas receptor mRNA in liver tissues.

Results: The levels of FINS in the study and control groups decreased, relative to normal control, while the levels of IRI was elevated (p < 0.05). There were significant increases in study group levels of Mas and ACE2, while angiot-(1-7) was lower, relative to control group (p < 0.05). The expressions of ACE2 and Mas receptors in study and diabetic control rats groups were downregulated, when compared to normal control. The expressions of ACE2 and Mas receptors also decreased in the study group exposed to angiot-(1-7) (p < 0.05).

Conclusion: Angiot-(1-7) significantly increases the levels of FINS and IR, improves hepatic glucose metabolism and enhances ACE2-angiot-(1-7)-Mas pathway. Thus, angiot-(1-7) may be a new drug candidate for the treatment of type 2 diabetes.

Keywords: Angiotensin-(1-7), Type-2 diabetes mellitus, ACE2-ang (1-7)-Mas pathway, Liver metabolism, Insulin resistance